Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study.

Address: School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.; MRC/University of Bristol Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.; School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.; MRC/University of Bristol Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.; The NIHR Bristol Nutrition Biomedical Research Unit, University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, United Kingdom.; The Institute of Cancer Research, London, SM2 5NG, United Kingdom.; Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom.; Strangeways Laboratory, Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Worts Causeway, Cambridge, United Kingdom.; The Institute of Cancer Research, London, SM2 5NG, United Kingdom.; Institute of Population Health, University of Manchester, Manchester, United Kingdom.; The Cancer Council Victoria, Cancer Epidemiology Centre, 1 Rathdowne Street, Carlton, Vic, Australia.; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Vic, Australia.; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.; Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA.; Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland.; Institute of Biomedical Technology/BioMediTech, University of Tampere and FimLab Laboratories, Tampere, Finland.; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Denmark.; Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Surgical Oncology (Uro-Oncology: S4), University of Cambridge, Box 279, Addenbrooke's Hospital, Hills Road, Cambridge, United Kingdom.; Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, United Kingdom.; School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.; Nuffield Department of Surgery, University of Oxford, Oxford, United Kingdom.; Strangeways Laboratory, Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Worts Causeway, Cambridge, United Kingdom.; Department of Applied Health Research, University College London, 1-19 Torrington Place, London, WC1E 7HB, United Kingdom.; Cambridge Institute of Public Health, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0SR, United Kingdom.; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA.; International Epidemiology Institute, 1455 Research Blvd, Suite 550, Rockville, MD.; Mayo Clinic, Rochester, MN.; Department of Urology, University Hospital Ulm, Germany.; Institute of Human Genetics University Hospital Ulm, Germany.; Brigham and Women's Hospital/Dana-Farber Cancer Institute, 45 Francis Street-ASB II-3, Boston, MA.; Washington University, St Louis, MO.; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.; Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT.; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Cancer Prevention and Control, H. Lee Moffitt Cancer Center, 12902 Magnolia Dr, Tampa, FL.; Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University Sofia, 2 Zdrave St, Sofia, 1431, Bulgaria.; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and Schools of Life Science and Public Health, Queensland University of Technology, BNE, Australia.; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal.; The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.